GPX3 and neoplasm: In adjacent non-tumor tissues, intense immunostaining for GPX3 was observed in a cytoplasmic distribution (Figure 3B), whereas absent/weak immunostaining was detected in the cytoplasm of tumor tissues (Figure 3B).